Jade Biosciences (JBIO) Interest Expenses (2020 - 2026)
Jade Biosciences (JBIO) posted Interest Expenses of $1.1 million for Q1 2026, down 96.38% on a QoQ basis from $29.3 million in Q3 2025, and down 62.14% year-over-year from $2.8 million in Q1 2025.
Jade Biosciences (JBIO) Interest Expenses (2020 - 2026) Analysis & Trends
Jade Biosciences' Interest Expenses history runs 7 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- Quarterly Interest Expenses fell 62.14% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 62.79% YoY) and the FY2025 annual result came in at $3.6 million, down 52.36% from the prior year.
- Interest Expenses was $1.1 million for Q1 2026 at Jade Biosciences, down from $29.3 million in the prior quarter.
- Across five years, Interest Expenses topped out at $93.5 million in Q1 2024 and bottomed at -$70000.0 in Q4 2022.
- A 5-year average of $24.5 million and a median of $29.3 million in 2025 frame the typical range for Interest Expenses.
- Peak annual rise in Interest Expenses reached 4111000.0% in 2022, while the deepest fall reached 6900.0% in 2022.
- Jade Biosciences' Interest Expenses stood at -$70000.0 in 2022, then jumped by 270.0% to $119000.0 in 2023, then tumbled by 89.92% to $12000.0 in 2024, then surged by 244108.33% to $29.3 million in 2025, then plunged by 96.38% to $1.1 million in 2026.
- Business Quant data shows JBIO's Interest Expenses at $1.1 million in Q1 2026, $29.3 million in Q3 2025, and $42.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - | 1.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.06 Mn |
| Mar 31, 2026 | 1.06 Mn |
| Sep 30, 2025 | 29.31 Mn |
| Sep 30, 2025 | 29.31 Mn |
| Jun 30, 2025 | 42.22 Mn |
| Jun 30, 2025 | 42.22 Mn |
| Mar 31, 2025 | 2.80 Mn |
| Mar 31, 2025 | 2.80 Mn |
| Sep 30, 2024 | 12,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 710,000.00 |
| Jun 30, 2024 | 710,000.00 |
| Mar 31, 2024 | 93.46 Mn |
| Mar 31, 2024 | 93.46 Mn |
| Dec 31, 2023 | 119,000.00 |
| Dec 31, 2023 | 119,000.00 |
| Sep 30, 2023 | 17.75 Mn |
| Sep 30, 2023 | 17.75 Mn |
| Jun 30, 2023 | 29.92 Mn |
| Jun 30, 2023 | 29.92 Mn |